The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NGS Based Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
The global NGS Based Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NGS Based Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics and Academics/Research Institutions,, are propelling NGS Based Diagnostics market. DNA Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA Sequencing segment is estimated at % CAGR for the next seven-year period.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS Based Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS Based Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS Based Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS Based Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS Based Diagnostics covered in this report include Janssen, Roche, Qiagen, ThermoFisher Scientific, Oxford Gene Technology, Illumina, Pacific Biosciences, Paradigm Diagnostics and Innogene Kalbiotech, etc.
The global NGS Based Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Global NGS Based Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS Based Diagnostics market, Segment by Type:
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Global NGS Based Diagnostics market, by Application
Hospitals
Clinics
Academics/Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS Based Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
The global NGS Based Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NGS Based Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics and Academics/Research Institutions,, are propelling NGS Based Diagnostics market. DNA Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA Sequencing segment is estimated at % CAGR for the next seven-year period.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS Based Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS Based Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS Based Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS Based Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS Based Diagnostics covered in this report include Janssen, Roche, Qiagen, ThermoFisher Scientific, Oxford Gene Technology, Illumina, Pacific Biosciences, Paradigm Diagnostics and Innogene Kalbiotech, etc.
The global NGS Based Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Global NGS Based Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS Based Diagnostics market, Segment by Type:
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Global NGS Based Diagnostics market, by Application
Hospitals
Clinics
Academics/Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS Based Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of NGS Based Diagnostics
1.1 NGS Based Diagnostics Market Overview
1.1.1 NGS Based Diagnostics Product Scope
1.1.2 NGS Based Diagnostics Market Status and Outlook
1.2 Global NGS Based Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global NGS Based Diagnostics Market Size by Region (2018-2029)
1.4 Global NGS Based Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global NGS Based Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, NGS Based Diagnostics Market Size (2018-2029)
1.6.1 North America NGS Based Diagnostics Market Size (2018-2029)
1.6.2 Europe NGS Based Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific NGS Based Diagnostics Market Size (2018-2029)
1.6.4 Latin America NGS Based Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa NGS Based Diagnostics Market Size (2018-2029)
2 NGS Based Diagnostics Market by Type
2.1 Introduction
2.1.1 DNA Sequencing
2.1.2 RNA Sequencing
2.1.3 Whole Genome Sequencing
2.1.4 Whole Exome Sequencing
2.1.5 Other
2.2 Global NGS Based Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global NGS Based Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America NGS Based Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe NGS Based Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific NGS Based Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America NGS Based Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa NGS Based Diagnostics Revenue Breakdown by Type (2018-2029)
3 NGS Based Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academics/Research Institutions
3.2 Global NGS Based Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global NGS Based Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America NGS Based Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe NGS Based Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific NGS Based Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America NGS Based Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa NGS Based Diagnostics Revenue Breakdown by Application (2018-2029)
4 NGS Based Diagnostics Competition Analysis by Players
4.1 Global NGS Based Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2022)
4.3 Date of Key Players Enter into NGS Based Diagnostics Market
4.4 Global Top Players NGS Based Diagnostics Headquarters and Area Served
4.5 Key Players NGS Based Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 NGS Based Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Janssen
5.1.1 Janssen Profile
5.1.2 Janssen Main Business
5.1.3 Janssen NGS Based Diagnostics Products, Services and Solutions
5.1.4 Janssen NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Janssen Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche NGS Based Diagnostics Products, Services and Solutions
5.2.4 Roche NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Qiagen
5.3.1 Qiagen Profile
5.3.2 Qiagen Main Business
5.3.3 Qiagen NGS Based Diagnostics Products, Services and Solutions
5.3.4 Qiagen NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 ThermoFisher Scientific Recent Developments
5.4 ThermoFisher Scientific
5.4.1 ThermoFisher Scientific Profile
5.4.2 ThermoFisher Scientific Main Business
5.4.3 ThermoFisher Scientific NGS Based Diagnostics Products, Services and Solutions
5.4.4 ThermoFisher Scientific NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 ThermoFisher Scientific Recent Developments
5.5 Oxford Gene Technology
5.5.1 Oxford Gene Technology Profile
5.5.2 Oxford Gene Technology Main Business
5.5.3 Oxford Gene Technology NGS Based Diagnostics Products, Services and Solutions
5.5.4 Oxford Gene Technology NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Oxford Gene Technology Recent Developments
5.6 Illumina
5.6.1 Illumina Profile
5.6.2 Illumina Main Business
5.6.3 Illumina NGS Based Diagnostics Products, Services and Solutions
5.6.4 Illumina NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Illumina Recent Developments
5.7 Pacific Biosciences
5.7.1 Pacific Biosciences Profile
5.7.2 Pacific Biosciences Main Business
5.7.3 Pacific Biosciences NGS Based Diagnostics Products, Services and Solutions
5.7.4 Pacific Biosciences NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Pacific Biosciences Recent Developments
5.8 Paradigm Diagnostics
5.8.1 Paradigm Diagnostics Profile
5.8.2 Paradigm Diagnostics Main Business
5.8.3 Paradigm Diagnostics NGS Based Diagnostics Products, Services and Solutions
5.8.4 Paradigm Diagnostics NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Paradigm Diagnostics Recent Developments
5.9 Innogene Kalbiotech
5.9.1 Innogene Kalbiotech Profile
5.9.2 Innogene Kalbiotech Main Business
5.9.3 Innogene Kalbiotech NGS Based Diagnostics Products, Services and Solutions
5.9.4 Innogene Kalbiotech NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Innogene Kalbiotech Recent Developments
5.10 Admera Health
5.10.1 Admera Health Profile
5.10.2 Admera Health Main Business
5.10.3 Admera Health NGS Based Diagnostics Products, Services and Solutions
5.10.4 Admera Health NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Admera Health Recent Developments
5.11 AITbiotech
5.11.1 AITbiotech Profile
5.11.2 AITbiotech Main Business
5.11.3 AITbiotech NGS Based Diagnostics Products, Services and Solutions
5.11.4 AITbiotech NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 AITbiotech Recent Developments
5.12 Centogene
5.12.1 Centogene Profile
5.12.2 Centogene Main Business
5.12.3 Centogene NGS Based Diagnostics Products, Services and Solutions
5.12.4 Centogene NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Centogene Recent Developments
5.13 Phalanx Biotech Group
5.13.1 Phalanx Biotech Group Profile
5.13.2 Phalanx Biotech Group Main Business
5.13.3 Phalanx Biotech Group NGS Based Diagnostics Products, Services and Solutions
5.13.4 Phalanx Biotech Group NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Phalanx Biotech Group Recent Developments
5.14 iGenomX
5.14.1 iGenomX Profile
5.14.2 iGenomX Main Business
5.14.3 iGenomX NGS Based Diagnostics Products, Services and Solutions
5.14.4 iGenomX NGS Based Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 iGenomX Recent Developments
6 North America
6.1 North America NGS Based Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NGS Based Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NGS Based Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NGS Based Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NGS Based Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NGS Based Diagnostics Market Dynamics
11.1 NGS Based Diagnostics Industry Trends
11.2 NGS Based Diagnostics Market Drivers
11.3 NGS Based Diagnostics Market Challenges
11.4 NGS Based Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
